You searched for "outcomes"

1708 results found

Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?

Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...

In conversation with Marc Labetoulle

Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...

Review of international telemedicine infrastructure for ROP

This review aimed to review the information and communications technology available for telemedicine, the internet access and economic status of countries at greater risk for higher prevalence of ROP, the framework of established ROP telemedicine programmes, and the cost-effectiveness of...

Why Ophthalmology?

Ophthalmology is a medical specialty that deals with eye diseases and helps preserve vision. The ophthalmic community consists of a wide range of healthcare professionals who work together to address eye-related problems in many extraordinary ways. This article explores the...

Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service

The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...

Developments in retinal pigmentation measurement and the hopes of an equitable future

Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

Quality matters in the management of serious eye disorders

The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...

People watching…

Confession time: I love a good airport lounge! Not only does it mean that you are about to go get some sunshine on a well-deserved break, it also provides a perfect opportunity to watch people go by. And what a...

Surgical strategies to manage incomitant strabismus in adults

Incomitant vertical and / or horizontal strabismus is a challenging presentation. Patients are usually symptomatic as the onset is either sudden so they haven’t developed any coping mechanisms or very complex so that any coping mechanisms will not cover all...

The results of the last survey Oct 2019

Another fascinating response which once more highlights the massive variation in practice. I completely acknowledge that ophthalmology is an art as well as a science and therefore there will be variances in practice and there will not be one ‘right’...

“My cataracts have been dissolved by eye drops!”

Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “My cataracts have been dissolved by eye drops!” I’m sure some of us have had patients enquire...

Help the VISION 2020 LINKS & Networks Programme to save children’s sight and lives

The LINKS & Networks Programme was established at the International Centre for Eye Health (ICEH), London School of Health and Tropical Medicine (LSHTM), 20 years ago to improve the quality and quantity of eye health services in low- and middle-income...